Literature DB >> 31837230

Effect of alcohol use disorders and alcohol intake on the risk of subsequent depressive symptoms: a systematic review and meta-analysis of cohort studies.

Jiande Li1, Hongxuan Wang1, Mei Li1, Qingyu Shen1, Xiangpen Li1, Yuanpei Zhang1, Jialing Peng1, Xiaoming Rong1, Ying Peng1,2.   

Abstract

BACKGROUND AND AIMS: Alcohol use disorders (AUD) are often comorbid with depressive symptoms. Cohort studies on the association between AUD and subsequent depressive symptoms have produced inconsistent results. Moreover, regarding alcohol intake, the risk of developing depressive symptoms might vary with alcohol intake level. We aimed to investigate the association between AUD, alcohol intake and subsequent depressive symptoms. DESIGN AND
SETTING: We conducted a systematic search in PubMed, Embase and PsycINFO for cohort studies on the association between AUD or alcohol intake and subsequent depressive symptoms. PARTICIPANTS: We included 338 426 participants from 42 studies. Six and four studies analyzed only females and males, respectively. MEASUREMENTS: We combined risk estimates for developing depressive symptoms using a random-effects model. We divided alcohol intake into abstinence, light (0-84 g/week), moderate (85-168 g/week) and heavy drinking (> 168 g/week or > 48 g/day at least weekly). We conducted a categorical analysis to compare the risk of depressive symptoms between abstinence and different intake categories. Further, we conducted a dose-response analysis to investigate the alcohol-depression association.
FINDINGS: We analyzed 42 studies (follow-up time: 1-40 years). AUD was associated with significantly increased risk of subsequent depressive symptoms [relative risk (RR) = 1.57, 95% confidence interval (CI) = 1.41-1.76]. Regarding alcohol intake, heavy drinking had an increased risk of depressive symptoms; however, the association was only significant when controls were limited to non-heavy drinkers (RR = 1.13, 95% CI = 1.05-1.22). Taking into consideration the possibility of publication bias and confounding factors made the association non-significant. We observed J-shaped associations in both categorical and dose-response analyses where light-moderate drinking had a significantly decreased risk of depression, while heavy drinking did not show a significant association with depressive symptoms compared with non-drinkers.
CONCLUSION: Alcohol use disorders are associated with increased the risk of subsequent depressive symptoms. Heavy drinking does not significantly predict occurrence of depressive symptoms after adjusting for potential confounders.
© 2019 Society for the Study of Addiction.

Entities:  

Keywords:  AUD; Alcohol misuse; alcohol dependence; alcohol use disorders; depression; depressive symptoms

Mesh:

Year:  2020        PMID: 31837230     DOI: 10.1111/add.14935

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  13 in total

1.  Socioeconomic status, alcohol use disorders, and depression: A population-based study.

Authors:  Aurélie M Lasserre; Sameer Imtiaz; Michael Roerecke; Markus Heilig; Charlotte Probst; Jürgen Rehm
Journal:  J Affect Disord       Date:  2022-01-02       Impact factor: 4.839

2.  Racial discrimination, depressive symptoms, ethnic-racial identity, and alcohol use among Black American college students.

Authors:  Jinni Su; Eleanor K Seaton; Chelsea D Williams; Danielle M Dick
Journal:  Psychol Addict Behav       Date:  2021-08

3.  Association between successful aging transitions and depressive symptoms among older Korean adults: findings from the Korean longitudinal study of aging (2006-2018).

Authors:  Fatima Nari; Bich Na Jang; Selin Kim; Wonjeong Jeong; Sung-In Jang; Eun-Cheol Park
Journal:  BMC Geriatr       Date:  2021-06-09       Impact factor: 3.921

4.  Symptoms of major depressive disorder during the COVID-19 pandemic: results from a representative sample of the Canadian population.

Authors:  Margot Shields; Lil Tonmyr; Andrea Gonzalez; Murray Weeks; Su-Bin Park; Anne-Marie Robert; Dawn-Li Blair; Harriet L MacMillan
Journal:  Health Promot Chronic Dis Prev Can       Date:  2021-09-27       Impact factor: 3.240

5.  Impulsivity Scale-12 and its utilization in alcohol use disorder.

Authors:  Jan Szczypiński; Andrzej Jakubczyk; Maciej Kopera; Elisa Trucco; Marcin Wojnar
Journal:  Drug Alcohol Depend       Date:  2021-06-18       Impact factor: 4.852

6.  Schoolteachers with voice handicap are twice as likely to report depressive symptoms.

Authors:  Alberto Durán González; Ana Carolina Bertin de Almeida Lopes; Selma Maffei de Andrade; Flávia Lopes Gabani; Mayara Cristina da Silva Santos; Renne Rodrigues; Arthur Eumann Mesas
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-04-20       Impact factor: 3.236

7.  Efficacy of pharmacotherapeutics for patients comorbid with alcohol use disorders and depressive symptoms-A bayesian network meta-analysis.

Authors:  Jiande Li; Hongxuan Wang; Mei Li; Qingyu Shen; Xiangpen Li; Xiaoming Rong; Ying Peng
Journal:  CNS Neurosci Ther       Date:  2020-07-19       Impact factor: 5.243

8.  Factors contributing to psychological distress in the working population, with a special reference to gender difference.

Authors:  Satu Viertiö; Olli Kiviruusu; Maarit Piirtola; Jaakko Kaprio; Tellervo Korhonen; Mauri Marttunen; Jaana Suvisaari
Journal:  BMC Public Health       Date:  2021-03-29       Impact factor: 3.295

9.  Using Mendelian randomization analysis to better understand the relationship between mental health and substance use: a systematic review.

Authors:  Jorien L Treur; Marcus R Munafò; Emma Logtenberg; Reinout W Wiers; Karin J H Verweij
Journal:  Psychol Med       Date:  2021-05-25       Impact factor: 7.723

10.  Bioinformatics identification and pharmacological validation of Kcnn3/KCa2 channels as a mediator of negative affective behaviors and excessive alcohol drinking in mice.

Authors:  Audrey E Padula; Jennifer A Rinker; Marcelo F Lopez; Megan K Mulligan; Robert W Williams; Howard C Becker; Patrick J Mulholland
Journal:  Transl Psychiatry       Date:  2020-11-27       Impact factor: 7.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.